Geneva Advisors’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2017
Q2 | $687K | Buy |
6,642
+4,188
| +171% | +$433K | 0.01% | 440 |
|
2017
Q1 | $240K | Buy |
2,454
+27
| +1% | +$2.64K | ﹤0.01% | 644 |
|
2016
Q4 | $215K | Sell |
2,427
-765
| -24% | -$67.8K | ﹤0.01% | 660 |
|
2016
Q3 | $308K | Buy |
+3,192
| New | +$308K | 0.01% | 573 |
|
2015
Q3 | – | Sell |
-4,725
| Closed | -$581K | – | 666 |
|
2015
Q2 | $581K | Buy |
4,725
+1,635
| +53% | +$201K | 0.01% | 404 |
|
2015
Q1 | $354K | Buy |
3,090
+705
| +30% | +$80.8K | 0.01% | 482 |
|
2014
Q4 | $241K | Buy |
+2,385
| New | +$241K | ﹤0.01% | 566 |
|